Global Aspirin Market Size, Share, and COVID-19 Impact Analysis, By Dosage Form (Injections, Capsules, and Tablets), By Product (Prescription and Over-the-Counter (OTC)), By Application (Cardiovascular Diseases, Inflammation, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Global Aspirin Market Insights Forecasts to 2033

• The Global Aspirin Market Size Was Estimated at USD 2420.12 Million in 2023
• The Market Size is Expected to Grow at a CAGR of around 2.62% from 2023 to 2033
• The Worldwide Aspirin Market Size is Expected to Reach USD 3133.40 Million by 2033
• Asia Pacific is predicted to grow at the fastest CAGR throughout the projection period

The Global Aspirin Market Size is predicted to exceed USD 3133.40 million by 2033, growing at a CAGR of 2.62% from 2023 to 2033.

Market Overview

The aspirin market emphasizes the development, production, and commercialization of aspirin which is used as a non-steroidal anti-inflammatory agent and anti-platelet drug. Aspirin is a trademark owned by the German pharmaceutical company Bayer. The generic term for aspirin is acetylsalicylic acid. Aspirin, a salicylate, and NSAID, is used to reduce fever and mild to moderate pain from various conditions like muscle aches, toothaches, common colds, and headaches. It may also alleviate pain and swelling in arthritis. It works by blocking a natural substance in the body. Low doses of aspirin may be prescribed to prevent blood clots, reducing the risk of stroke and heart attack. Patients with recent clogged arteries use aspirin as a "blood thinner" to prevent blood clots. Aspirin is increasingly used to treat and prevent heart attacks and strokes, driven by the increasing prevalence of these disorders globally. Technological advancements in drug delivery systems have enabled the creation of aspirin formulations with variable release times, allowing controlled aspirin release and potentially minimizing gastrointestinal adverse effects. These developments improve patient adherence and support the expansion of the aspirin market, as heart attacks and strokes become more prevalent.

Report Coverage

This research report categorizes the global aspirin market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global aspirin market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global aspirin market.

Driving Factors:

The aspirin market is experiencing growth due to the increasing incidence of cardiovascular diseases globally. These diseases are the leading cause of death, leading to a rise in the use of low-dose aspirin to prevent heart attacks and strokes. Aspirin's benefits in cardiovascular health management are driving doctor recommendations and consumer self-medication, boosting demand. Medical research is also expanding its use to new therapeutic areas, contributing to market growth. The aging population is more susceptible to chronic conditions like cardiovascular diseases and arthritis, which may require aspirin for long-term management.

The convenience of retail and online pharmacies is making aspirin more accessible, further supporting market expansion. Research into aspirin's potential role in cancer prevention and treatment of inflammatory conditions is also paving the way for future market expansion. This expansion into diverse applications is expected to sustain demand and contribute to the steady growth of the aspirin market over the forecast period.

Restraining Factors

The side effects associated with aspirin include vomiting, idiosyncrasy, and salicylate intolerance, accessibility of alternative medications, high cost of the branded drugs of aspirin, gastrointestinal issues, such as bleeding and ulcers, and stringent guidelines of the regulatory authorities might restrict the growth of the market.

Market Segmentation

The global aspirin market share is classified into dosage form, product, and application.

• The tablets segment dominated the market with 62.83% of the share in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period.

Based on the dosage form, the global aspirin market is categorized into injections, capsules, and tablets. Among these, the tablets segment dominated the market with 62.83% of the share in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period. The segmental expansion is attributed to the greater efficacy of tablets than capsules, rapid onset of action, ease of administration, greater stability, prolonged shelf-life, enhanced bioavailability, cost-effectiveness, and availability in the targeted drug delivery system such as controlled release tablets, and tablets are suitable to the pediatric and geriatric population as it undergoes the sugar coating and film coating it prevents from the unpleasant taste.

• The over-the-counter (OTC) segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.

Based on the product, the global aspirin market is categorized into prescription and over-the-counter (OTC). Among these, the over-the-counter (OTC) segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segment's growth is owing to the rise in the occurrence of common allergies, colds, flu, and fever, the growing trend of online pharmacies, available in retail locations, cost-effectiveness, and the increasing prevalence of lifestyle diseases.

• The inflammation segment accounted for the fastest growth rate in 2023.

Based on the application, the global aspirin market is categorized into inflammation, cardiovascular diseases, and others. Among these, the inflammation segment accounted for the fastest growth rate in 2023. This segment growth is ascribed to the increasing prevalence of inflammatory diseases such as arthritis, and psoriasis, aspirin is more effective in relieving inflammation as a low dose of aspirin is required, and inhibits the action of inflammatory mediators.

Regional Segment Analysis of the Global Aspirin Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global Aspirin market over the predicted timeframe.

North America is anticipated to hold the largest share of the global Aspirin market over the predicted timeframe. The market growth in this region is primarily due to the surge in demand for anti-inflammatory drugs, and rising cases of cardiovascular diseases, common cold, and flu prevalent among Americans which results in the growth of the market, leading region in the aspirin sales, innovations in the aspirin drug delivery, presence of numerous manufacturing companies of the aspirin, growing awareness of cardiovascular diseases among citizens.

Asia Pacific is anticipated to grow at the fastest CAGR throughout the projected timeframe. The Asia-Pacific region is expected to experience the highest growth in the global aspirin market due to the robust pharmaceutical industry, particularly in China and India. These nations are world leaders in producing Active Pharmaceutical Ingredients (APIs) and cater to global drug manufacturers. Asia's large population base results in higher sales of basic medicines like aspirin, and the densely populated regions also contribute to the spread of contagious diseases like cold and flu. The rapid expansion of pharmacies providing OTC medicines, rising numbers of cardiovascular disease patients, and increased healthcare expenditure could further drive regional market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global aspirin market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Bal Pharma Limited
• Umang Pharmatech Pvt. Ltd. 
• Mayne Pharma Group Limited
• Par Pharmaceutical
• Cardinal Health
• Globela Pharma Pvt. Ltd
• Allegiant Health
• LNK International, Inc.
• Perrigo Company plc
• Anastacio Chemistry
• Trumac Healthcare
• Bayer AG
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In February 2025, on the occasion of Bayer’s 125^th anniversary of the aspirin discovery, Bayers focused and developed innovative approaches to cardiovascular health, and aimed to increase access to personalized care and prevent cardiovascular disease. This research emphasized viewing cardiovascular risk as a continuum and using affordable tools such as Carotid Ultrasound to assess individual risk, enhancing treatment options of aspirin. This research was supported by a Bayer grant.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global aspirin market based on the below-mentioned segments:

Global Aspirin Market, By Dosage form

• Injections
• Capsules
• Tablets

Global Aspirin Market, By Product

• Prescription
• Over-the-Counter (OTC)

Global Aspirin Market, By Application

• Cardiovascular diseases
• Inflammation
• Others

Global Aspirin Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa